ALDRABIX Trademark

Trademark Overview

On Monday, September 13, 2010, a trademark application was filed for ALDRABIX with the United States Patent and Trademark Office. The USPTO has given the ALDRABIX trademark a serial number of 79089984. The federal status of this trademark filing is IR CANCELLED - US REGISTRATION CANCELLED as of Monday, September 14, 2020. This trademark is owned by Pronova BioPharma Norge AS. The ALDRABIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products in the form of unsaturated fatty acids for the prevention or treatment of metabolic diseases
aldrabix

General Information

Serial Number79089984
Word MarkALDRABIX
Filing DateMonday, September 13, 2010
Status404 - IR CANCELLED - US REGISTRATION CANCELLED
Status DateMonday, September 14, 2020
Registration Number4054621
Registration DateTuesday, November 15, 2011
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 30, 2011

Trademark Statements

Goods and ServicesPharmaceutical products in the form of unsaturated fatty acids for the prevention or treatment of metabolic diseases

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, June 22, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBASF AS
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressNO
Party NamePronova BioPharma Norge AS
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressNO
Party NamePronova BioPharma Norge AS
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressNO

Trademark Events

Event DateEvent Description
Saturday, April 17, 2021NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Saturday, April 17, 2021DEATH OF INTERNATIONAL REGISTRATION
Friday, April 5, 2019TOTAL INVALIDATION PROCESSED BY THE IB
Tuesday, March 5, 2019TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, March 5, 2019INVALIDATION PROCESSED
Friday, February 22, 2019TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Thursday, November 8, 2018CHANGE OF NAME/ADDRESS REC'D FROM IB
Friday, June 22, 2018CANCELLED SECTION 71
Tuesday, November 15, 2016COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Thursday, August 27, 2015NEW REPRESENTATIVE AT IB RECEIVED
Friday, May 25, 2012FINAL DECISION TRANSACTION PROCESSED BY IB
Monday, May 7, 2012FINAL DISPOSITION NOTICE SENT TO IB
Monday, May 7, 2012FINAL DISPOSITION PROCESSED
Wednesday, February 15, 2012FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Friday, January 6, 2012NOTIFICATION PROCESSED BY IB
Tuesday, November 15, 2011REGISTERED-PRINCIPAL REGISTER
Tuesday, August 30, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 30, 2011PUBLISHED FOR OPPOSITION
Wednesday, August 10, 2011NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, August 10, 2011NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Tuesday, July 26, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, July 21, 2011ASSIGNED TO LIE
Monday, June 27, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, June 14, 2011ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, June 14, 2011TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, June 14, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 14, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 14, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, January 22, 2011REFUSAL PROCESSED BY IB
Wednesday, January 5, 2011NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Wednesday, January 5, 2011REFUSAL PROCESSED BY MPU
Wednesday, January 5, 2011NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, January 4, 2011NON-FINAL ACTION WRITTEN
Thursday, December 30, 2010ASSIGNED TO EXAMINER
Monday, December 27, 2010ASSIGNED TO EXAMINER
Saturday, December 25, 2010APPLICATION FILING RECEIPT MAILED
Tuesday, December 21, 2010ASSIGNED TO EXAMINER
Tuesday, December 21, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, December 17, 2010LIMITATION FROM ORIGINAL APPLICATION ENTERED
Thursday, December 16, 2010SN ASSIGNED FOR SECT 66A APPL FROM IB

Related Keywords

aldrabix prevention treatment metabolic diseases acids fatty products form unsaturated pharmaceutical